![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1433402
¼¼°èÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå(2023-2030³â)Global Laboratory Proficiency Testing Market 2023-2030 |
¼¼°èÀÇ ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â)¿¡ CAGR 7.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è »ê¾÷¿¡¼ ǰÁú º¸Áõ¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±âÀÎÇÕ´Ï´Ù. ǰÁú º¸ÁõÀº ¼ÒºñÀÚÀÇ ½Å·Ú¿Í ±ÔÁ¦ ±âÁØ Áؼö¸¦ À¯ÁöÇϱâ À§ÇØ Æ¯È÷ À½·á ¹× ½Äǰ »ê¾÷¿¡¼ ¿ì¼±ÀûÀ¸·Î ½ÃÇàµÇ°í ÀÖÀ¸¸ç, 2022³â 4¿ù BIPEA´Â ½Äǰ¿¡¼ SEA-SEEÇü Æ÷µµ»ó±¸±Õ¼º Àåµ¶¼Ò¸¦ °ËÃâÇÒ ¼ö ÀÖ´Â »õ·Î¿î ½ÃÇè¼Ò °£ ½ÃÇè(PTS 111)À» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ½ÃÇèÀº ¾×ü ¿ìÀ¯ »ùÇÿ¡¼ Æ÷µµ»ó±¸±Õ¼º Àåµ¶¼Ò °ËÃâÀ» Æò°¡Çϱâ À§ÇÑ ¿¹ºñ ½ÃÇè¿ë ¿ìÀ¯ ¸ÅÆ®¸¯½º¸¦ ±ÔÁ¤Çϰí ÀÖ½À´Ï´Ù.
¾÷Á¾º°·Î´Â ¹Ì»ý¹°ÇÐ ÇÏÀ§ ºÎ¹®ÀÌ ¼¼°è ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀå¿¡¼ »ó´çÇÑ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ¹Ì»ý¹°ÇÐ ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀÌ È®´ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÈÀåǰ Á¦Á¦ÀÇ ¹Ì»ý¹° ¿À¿°À» º¸´Ù Á¤È®Çϰí Á¾ÇÕÀûÀ¸·Î ½Äº°ÇÒ ¼ö ÀÖ´Â ¹Ì»ý¹° °Ë»ç ¹æ¹ý°ú ±â¼úÀº ±â¼ú Å×½ºÆ® »ê¾÷À» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 8¿ù BIPEA´Â Ãֽбâ¼ú ½ÃÇèÀÎ PT 114 ÈÀåǰ ¹Ì»ý¹° 縰Áö ½ÃÇèÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥ÀÇ ¸ñÀûÀº ½ÃÇè¼Ò°¡ ÈÀåǰ Á¦Á¦¿¡ ´ëÇÑ ¹Ì»ý¹° 縰Áö Å×½ºÆ®¸¦ ¼öÇàÇÏ´Â ´É·ÂÀ» µ¶¸³ÀûÀ¸·Î Æò°¡ÇÏ´Â °ÍÀÔ´Ï´Ù.
¼¼°è ÀÓ»ó °Ë»ç ±â´É ½ÃÇè ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾Æ Áö¿ª), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¶óƾ¾Æ¸Þ¸®Ä«) µî Áö¿ªº°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ´õ ¼¼ºÐȵ˴ϴÙ. ±× Áß¿¡¼µµ ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ±¹Á¦ÀûÀÎ ÀÚ°ÝÀ» ÃëµæÇÏ·Á´Â °Ë»ç±â°üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è Àüü¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ðµç Áö¿ª Áß ºÏ¹Ì´Â ¿¹Ãø ±â°£ Áß »ó´çÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀº °Ë»ç Á¤È®µµ ¹× ½Å·Ú¼º Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¼÷·Ãµµ Å×½ºÆ® ÇÁ·Î±×·¥Àº Á¤È®ÇÑ COVID-19 Áø´Ü¿¡ ÇʼöÀûÀÎ Å×½ºÆ® Á¤È®µµ¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀÔ´Ï´Ù. Àü¹ÝÀûÀÎ Á¤È®µµ¸¦ ³ôÀ̱â À§ÇØ ÀÌ ÇÁ·Î±×·¥À» ÅëÇØ °Ë»ç ±â°üÀº »ùÇà Ãë±Þ ¹× °Ë»ç ÀýÂ÷¸¦ Æ÷ÇÔÇÑ Àüü ¾÷¹« ÇÁ·Î¼¼½º¸¦ ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 4¿ù ¹Ì±¹º´¸®ÇÐȸ(CAP)´Â ÁßÁõ±Þ¼ºÈ£Èí±âÁõÈıº Äڷγª¹ÙÀÌ·¯½º2(SARS CoV-2) °ËÃâÀ» À§ÇÑ »õ·Î¿î ±â¼ú½ÃÇè(PT) ÇÁ·Î±×·¥À» ¹ßÇ¥Çß½À´Ï´Ù. ¹Ì»ý¹°ÇÐÀ§¿øÈ¸´Â SARS CoV-2 °ËÃâÀ» À§ÇÑ Çõ½ÅÀûÀÎ ÇÁ·ÎÁ§Æ®¸¦ ½Ã¹üÀûÀ¸·Î ½Ç½ÃÇÏ¿© ºñ°¨¿°¼º »ùÇÃÀ» Á¦°øÇÏ°í ½ÇÇè½Ç¿¡¼ ¿ÏÀüÇÑ ÀÛ¾÷À» °Ë»çÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù.
Global Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report by Industry Type (Clinical Diagnostics, Microbiology, Pharmaceuticals, Biologics, and Others), and by Technology (Polymerase Chain Reaction, Immunoassays, Chromatography, Spectrometry, and Others), Forecast Period (2023-2030)
The global laboratory proficiency testing market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The market's growth is attributed to the demand for quality assurance in the industry across the globe. The quality assurance is prioritized in industries, particularly in food and beverage, to maintain consumer trust and compliance with regulatory standards. The proficiency testing ensures the dependability of laboratory testing procedures. in April 2022,BIPEA is launched a new interlaboratory test (PTS 111) that allowed laboratories to detect Staphylococcal enterotoxins type SEA to SEE in food. It specifies milk matrix for preliminary testing, assessing staphylococcal enterotoxins detection in liquid milk samples.
The global laboratory proficiency testing market is segmented on the industry type, and technology. Based on the industry type, the market is sub-segmented into clinical diagnostics, microbiology, pharmaceuticals, biologics, and others. Furthermore, on the basis of technology, the market is sub-segmented into polymerase chain reaction, immunoassays, chromatography, spectrometry, and others. The clinical diagnostics subcategory is expected to capture a significant portion of the market share within the industry type segment. The growth can be attributed to the development of sophisticated diagnostic tests the need for early diagnosis, and the increased need for precise and reliable testing processes.
Among the industry type, the microbiology sub-segment is expected to hold a considerable share of the global Laboratory Proficiency Testing market. The segmental growth is attributed to the growing technological advancements in microbiology. The microbiological testing methodologies and technology that enable more accurate and comprehensive identification of microbial contamination of cosmetic formulations boost the proficiency testing industry. For instance, in August 2023, BIPEA launched latest proficiency test, PT 114 the Cosmetic Microbial Challenge test. The purpose of the program is to independently assess a laboratory's the ability to perform a Microbial Challenge test in cosmetic formulations.
The global laboratory proficiency testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising awareness of healthcare and a growing number of laboratories seeking to obtain international credentials in the region.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising demand for enhancing test accuracy and confidence. The proficiency testing programs develop dependence on testing accuracy, that's essential to accurate COVID-19 diagnosis. To improve overall accuracy, the program allows laboratories to analyze the whole operating process, including sample handling and testing procedures. For instance, in April 2020, The College of American Pathologists (CAP), released a new proficiency testing (PT) program for the detection of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). The Microbiology Committee piloted an innovative project for SARS CoV-2 detection, delivering non-infectious samples and allowing laboratories to examine the complete operation.
The major companies serving the laboratory proficiency testing market includes AOAC INTERNATIONAL, Laboratory Corp., LGC Ltd., Merck KGaA, Thermo Fisher Scientific Inc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Spex CertiPrep, NSI Lab Solutions, and the US Pharmacopeia (USP) partnered to provide a robust proficiency testing (PT) program for laboratories across the globe. The program raises laboratory and analyst performance awareness, supports the requirements for accreditation, enhances quality management systems, promotes industry reliability, and ensures regulator assurance across the product registration and durability.